metformin has been researched along with dextrothyroxine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 7 (77.78) | 2.80 |
| Authors | Studies |
|---|---|
| Baggio, G; Baiocchi, MR; Briani, G; Crepaldi, G; Fellin, R | 1 |
| Aoki, D; Banno, K; Kobayashi, Y; Kunitomi, H; Tominaga, E | 1 |
| Alonso, DF; Farina, HG | 1 |
| Bartosch, C; Henriques Abreu, M; Nunes, M; Ricardo, S | 1 |
| Anderson, B; Avula, N; Belani, HK; Biros, M; Boulware, DR; Bramante, CT; Buse, JB; Cohen, K; Erickson, SM; Fenno, SL; Fricton, R; Hagen, AA; Hartman, KM; Huling, JD; Ingraham, NE; Karger, AB; Klatt, NR; Lee, S; Liebovitz, DM; Lindberg, S; Luke, DG; Murray, TA; Nicklas, JM; Odde, DJ; Patel, B; Proper, JL; Pullen, MF; Puskarich, MA; Rao, V; Reddy, NV; Saveraid, HG; Sherwood, NE; Siegel, LK; Thompson, JL; Tignanelli, CJ; Tordsen, WJ; Zaman, A | 1 |
| Misra, S; Shukla, AK | 1 |
| Boulware, DR; Bramante, CT; Buse, JB | 1 |
| Anderson, BJ; Beckman, KB; Belani, HK; Bhat, NS; Boulware, DR; Bramante, CT; Buse, JB; Cohen, K; Erickson, SM; Fenno, SL; Griffiths, G; Hartman, KM; Huling, JD; Karger, AB; Klatt, NR; Liebovitz, DM; Lindberg, SM; Mehta, T; Murray, TA; Nicklas, JM; Odde, DJ; Patel, B; Proper, JL; Pullen, M; Puskarich, MA; Rose, MR; Sherwood, NE; Siegel, LK; Thompson, JL; Tignanelli, CJ; Wirtz, EL | 1 |
2 review(s) available for metformin and dextrothyroxine
| Article | Year |
|---|---|
Current state and outlook for drug repositioning anticipated in the field of ovarian cancer.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antiparasitic Agents; Carcinoma, Ovarian Epithelial; Diphosphonates; Drug Repositioning; Female; Health Care Costs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Itraconazole; Ivermectin; Metformin; Ovarian Neoplasms | 2019 |
Recycling the Purpose of Old Drugs to Treat Ovarian Cancer.
Topics: Diphosphonates; Drug Repositioning; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Itraconazole; Ivermectin; Metformin; Neoplasm Recurrence, Local; Ovarian Neoplasms; Ritonavir | 2020 |
2 trial(s) available for metformin and dextrothyroxine
| Article | Year |
|---|---|
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
Topics: Adult; Aged; Aged, 80 and over; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Double-Blind Method; Female; Fluvoxamine; Humans; Hypoxia; Ivermectin; Male; Metformin; Middle Aged; Obesity; Overweight; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2 | 2022 |
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial.
Topics: Adult; COVID-19; COVID-19 Drug Treatment; Double-Blind Method; Female; Fluvoxamine; Humans; Incidence; Ivermectin; Male; Metformin; Middle Aged; Outpatients; Post-Acute COVID-19 Syndrome; Pregnancy; SARS-CoV-2; Treatment Outcome | 2023 |
5 other study(ies) available for metformin and dextrothyroxine
| Article | Year |
|---|---|
[Treatment of hyperlipoproteinemias (author's transl)].
Topics: Adolescent; Adult; Anticholesteremic Agents; Child; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Ion Exchange Resins; Lipoproteins; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Metformin; Middle Aged; Nicotinic Acids; Phenformin | 1974 |
Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?
Topics: Anticholesteremic Agents; Antineoplastic Agents; Antiparasitic Agents; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Repositioning; Host-Pathogen Interactions; Humans; Hypoglycemic Agents; Ivermectin; Lovastatin; Metformin; Nitro Compounds; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severity of Illness Index; Thiazoles | 2020 |
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19.
Topics: COVID-19; Fluvoxamine; Humans; Ivermectin; Metformin | 2022 |
Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. Reply.
Topics: COVID-19; Fluvoxamine; Humans; Ivermectin; Metformin | 2022 |
COVID-19 update: Metformin to prevent long COVID?
Topics: COVID-19; Humans; Hypoglycemic Agents; Ivermectin; Metformin; Post-Acute COVID-19 Syndrome; SARS-CoV-2 | 2023 |